Zydus Lifesciences Announces 1100% Dividend with 18% YoY Growth in Q4 FY25

Zydus Lifesciences Ltd has announced its audited financial results for the quarter and year ended on March 31, 2025. The company reported a 18% YoY growth in revenue from operations for Q4 FY25, standing at Rs. 65,279 mn. Research & Development (R&D) investments for the quarter were Rs. 4,799 mn. The net profit, adjusted for exceptional items, was Rs. 13,905 mn, up 18% YoY. For the full year FY25, the revenue from operations was Rs. 2,32,415 mn, up 19% over last year. The net profit, adjusted for exceptional items, was Rs. 47,451 mn, up 23% YoY. The company's net debt to equity ratio as on 31st March, 2025 was -0.20x, and net debt to EBITDA stood at -0.69x at the end of March, 2025. Zydus Lifesciences recommended a dividend of 1100%.